Product Information
PRAMIPEXOLE 0.25 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.0472 per EA under NDC 50228012710. Its NADAC has been published 270 times since Jun 23, 2021.
FDA first approved this application on Oct 28, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.25 mg/1
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228012710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PRAMIPEXOLE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203855FDA Approved
10/28/2014
TE Code
AB
On Market Since
10/29/2014
Pharmacological Classes
Price Statistics
The NADAC for PRAMIPEXOLE 0.25 MG TABLET has been published 270 times since Jun 23, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0472 per EA |
|---|---|
| All-time high | $0.0583 (Dec 15, 2021) |
| All-time low | $0.0364 (Nov 20, 2024) |
| 52-week high | $0.0473 |
| 52-week low | $0.0456 |
| Median price | $0.0492 |
| Average price | $0.0493 |
| Largest weekly change | +24.4% (Jun 19, 2024) |
| Weeks tracked | 270 |
| Tracking since | Jun 23, 2021 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PRAMIPEXOLE 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE 0.25 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.0472 per EA (NDC 50228012710), effective Aug 19, 2026.
How has the price of PRAMIPEXOLE 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRAMIPEXOLE 0.25 MG TABLET has held within roughly two percent of its current level. It has been tracked across 270 weekly CMS publications since Jun 23, 2021.
What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE 0.25 MG TABLET?
Since Jun 23, 2021, the NADAC for PRAMIPEXOLE 0.25 MG TABLET has ranged from a low of $0.0364 (Nov 20, 2024) to a high of $0.0583 (Dec 15, 2021), with a median of $0.0492 per EA.
Are there cheaper alternatives to PRAMIPEXOLE 0.25 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PRAMIPEXOLE 0.25 MG TABLET, is $0.0457 per EA — about 3% below PRAMIPEXOLE 0.25 MG TABLET.
Who manufactures PRAMIPEXOLE 0.25 MG TABLET?
PRAMIPEXOLE 0.25 MG TABLET (NDC 50228012710) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.